about
Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study.Higher alleles of apolipoprotein B gene 3' VNTR: Risk for gallstone disease.Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.Current status and future prospect of FSHD region gene 1.MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy.Distinctive mutation spectrum of the HBB gene in an urban eastern Indian population.A Novel KERA Mutation in a Case of Autosomal Recessive Cornea Plana With Primary Angle-Closure Glaucoma.Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration.Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility.Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors.The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer.Dideoxy nucleoside triphosphate (ddNTP) analogues: Synthesis and polymerase substrate activities of pyrrolidinyl nucleoside triphosphates (prNTPs).Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease.Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasionA Cost-Effective and Efficient Chick Ex-Ovo CAM Assay Protocol to Assess Angiogenesis.Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: A case-control studyCholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancerMethylene Salicylicacidyl Hexamer (MSH) Has DNAse Activity
P50
Q24813755-58227B39-160F-4B2E-A5D9-0066EBEC3495Q36263081-435F36B6-6885-4BF9-9B49-FA70FCB3EB8FQ37134215-0598D08E-6D52-4FD7-899A-CBAF1EAA5099Q38676318-2E7CA3E5-2440-46D6-A86D-533FE94FA8FBQ39409527-E8A998F2-11B7-4278-8123-54C7F032597DQ40141850-E891EC6C-0959-4B17-9C55-0C23C66AEE93Q40946772-7E37DC45-3790-409D-97DD-CECCD540F59BQ46799572-9164033B-E299-4B72-BC97-5F331BD4CBC3Q46911425-A817B623-D74C-433E-B509-4E956F1F50B9Q46936501-4797ECBA-5C43-4DC7-AC3E-CB1A7F88917EQ47119855-382EFF0F-1260-4D62-852C-1A129CDB207DQ48226191-95810E44-D1B9-423D-977D-5E4662AC309CQ51907996-A58AC732-C376-4C13-8AF4-AAA59D3C0AD8Q54186762-E8E98EA2-3F0E-4AC3-9C02-027F517DE47CQ54601283-01266683-36E6-4E72-BEF0-5F3AB9AFBA33Q64053310-BF120FDF-274B-41BD-974A-53A42BFAF34BQ64921039-B0932A82-D12B-4C10-B127-305EB879ABB2Q79891361-803420BD-C8C9-4040-9AF5-28D518EE54D4Q81458963-AD01B096-C429-417E-A79E-52BA1BB0250BQ85383506-CC99ABEF-55B8-4C51-9111-4A4C81B0AC12
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6997-1054
@en
name
Manjusha Dixit
@ast
Manjusha Dixit
@en
Manjusha Dixit
@es
Manjusha Dixit
@nl
type
label
Manjusha Dixit
@ast
Manjusha Dixit
@en
Manjusha Dixit
@es
Manjusha Dixit
@nl
prefLabel
Manjusha Dixit
@ast
Manjusha Dixit
@en
Manjusha Dixit
@es
Manjusha Dixit
@nl
P106
P31
P496
0000-0002-6997-1054